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I almost had this month's column finished when I got the
news; then I knew I had to write a different one. The news
was that Dan Koshland, one of the truly titanic figures in
American science in the past 50 years, had died of a massive
stroke at age 87 on Monday, 23 July.
Dan always said that his ambition was to die young as old as
possible. He succeeded: very few people, of any age, have
had a younger heart or a more open mind.  He went the way
we should all go: suddenly, while still sharp and having fun.
In fact, he called his delightful autobiographical sketch
"How to get paid for having fun" (Koshland DE: Annu Rev
Biochem 1999,  65:1-13), and few scientists have enjoyed
themselves more. His scientific accomplishments were vast,
ranging from the development of fundamental concepts in
enzymology to important advances in understanding sensory
transduction through his work on bacterial chemotaxis. He
managed to combine a gift for theorizing with a talent for
clever but rigorous experiments - a feat that few have done
so well. And throughout it all he gave the impression that he
was just a kid playing with his favorite toy. 
He was my friend for over 30 years. I first met him when I
was a graduate student in England and he was on sabbatical
there. I knew who he was, of course - he was already famous
for his work on enzymes. In the late 1950s, he did a series of
experiments on the enzyme hexokinase that were
incompatible with the rigid 'lock-and-key' picture of how an
enzyme works that had stood as dogma for half a century. To
explain his results he formulated what he called the "induced
fit" theory, invoking a moderately flexible enzyme fitting
itself to a moderately flexible substrate. This revolutionary
advance in our thinking about how enzymes work was
greeted with resounding skepticism, which Dan recalled with
the relish of the vindicated in his wonderful essay "Crazy,
but correct" (Koshland DE: Nature 2004, 432:447). He also
had demonstrated the phenomenon of absolutely negative
cooperativity (where the binding of a ligand to one subunit
of a multi-subunit enzyme completely blocks binding to
another, identical subunit) and had proposed an alternative
model for allostery to the 'all-or-nothing', symmetrical
model of Monod, Wyman and Changeux. Dan's 'sequential'
model, in which some subunits can be in the tense (or T)
state while others are in the relaxed (R) state is now
generally acknowledged to be correct, at least for some
allosteric proteins. At the time we met he had just started to
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Daniel Koshland, circa 1991. Image courtesy of Robert Holmgren (UC
Berkeley News).work on bacterial chemotaxis, a field that had been
dominated for decades by beautiful genetics from the likes of
Julius Adler but which was lacking in any molecular
description of how a chemical signal generated a change in
behavior. Over the succeeding 20 years, Dan and his
students and postdocs, bringing not just the tools but also
the quantitative rigor of the enzymologist to bear on the
problem, delineated the structures and mechanisms of all of
the major players in this pathway. Dan's enthusiasm for this
new foray into cell biology - a field seemingly light years
removed from his biochemical research - made a deep
impression on me, and was largely responsible for my own
effort to learn yeast genetics many years later so I could
study the problem of cellular quiescence. ("Petsko," he said,
when I told him of my plans, "I see you have learned a
valuable lesson from me: if you have no conscience
whatsoever, you can ruin more than one field in your
lifetime.") At the time of his death he was excited about yet a
new venture, an effort to use light energy to improve the
efficiency of ethanol production from plant material.
Biofuels has been something of a stodgy field in recent years;
can there be any doubt that it would have become much
livelier - and more scientifically interesting - with Dan
Koshland in it?
For some reason he took a liking to me, and to my ideas. I
wasn't his student - there was nothing in it for him - but
nevertheless he became one of my biggest supporters over
the years (I suppose he has that to answer for, somewhere).
Time and time again something good would happen to me
and I would find out later that Dan was behind it. From the
day we met in England until the day he died, I always felt
like he was there for me, and I can't describe how important
that was. We often don't realize the influence we have over
others. We're supposed to be supportive of the people who
work with us, but sometimes it's the support we give the
stranger, the casual scientific acquaintance, that has the
greatest influence. When a senior scientist, especially one of
any eminence, takes an interest in a younger colleague, it can
have a transforming effect on that person's life and career.
I've been fortunate to have had several such supporters in
my life, and they've made a huge difference. It doesn't take
much, really: the right words at the right time, a phone call
or e-mail, a remark dropped in the right ear, a willingness to
write that letter or visit that poster or attend that talk. Who
knows what, if anything, I meant to Dan Koshland? I sure
know what he meant to me. 
I didn't know for many years that Dan was fabulously
wealthy - he was one of the heirs to the Levi-Strauss clothing
fortune. Everybody was surprised when they learned that,
because he was among the most down-to-earth people you
would ever meet. He wore his wealth like he wore his
scientific distinction: casually, unostentatiously. He used it
well, too: he helped build several buildings - at Berkeley,
where he taught since 1965, and in Washington, where he
provided a major gift to endow the Marian Koshland Science
Museum of the National Academy of Sciences, named after
his wife Marian (Bunny), herself a distinguished scientist (in
immunology). The couple were also the lead donors to the
Marian E Koshland Integrated Science Center at Haverford
College, which their two sons attended. 
In 1985 he accepted the position of editor-in-chief of the
journal Science. These days, when Science is considered one
of the highest-profile places in which to publish biological
research, it's hard to believe that it was once not even on the
top twenties list, but that was indeed the situation when Dan
took over. If you wanted to publish basic life sciences
research in a high-impact journal, you published in Nature.
Dan set out to change that, and did so, spectacularly. He
created a board of reviewing editors with heavy emphasis on
the biological sciences, brow-beat (charmingly, of course) his
friends (including me) into publishing their hottest stuff
there, and so changed the perception of the biological
community that, by the time the first genome sequence of a
free-living organism was completed, in 1995 by Claire
Fraser, Craig Venter and their associates, Science was
considered the most prestigious place for US life scientists to
publish earth-shaking discoveries - as in fact, they did
(Smith et al.: Science 1995, 269:495-511). Science continued
to lead the way in publishing new genome sequences for
some time, although Nature soon caught up. But Dan had
changed the journal completely, and much for the better.
He told me that the only reason he took the job, which
required him to fly to the East Coast almost every week for
ten years, was so that he would have a place where they had
to publish his little musings on any subject that took his
fancy. Numerous times each year, he wrote editorials for the
front of the journal - remarkable short essays on topics
ranging from spousal abuse to the Clinton Administration's
science appointments. They were always a delight to read -
still are, after all these years. They're funny, insightful,
irreverent, and candid. Dan never hesitated to speak his
mind but managed to do it in an offhand, witty way that was
both charming and effective. His style and fearlessness had a
big influence on me when I decided to do this column (so I
guess that's something else he has to answer for). Here's an
excerpt from an editorial he wrote on the scientific funding
crisis of 1990: "What is important is to think big about 'little
science'. There will undoubtedly be some megaprojects, but
what the nation and the world really need is a major
expansion of investigator-initiated science, because that
historically has been the source of great discoveries that have
opened new frontiers." (Is anybody in Washington listening
today?)
Dan was a big supporter of genomics, including the human
genome project. In 1989, when support for this biological
Manhattan Project was highly controversial, this is what he
said in one of his Science editorials: "We must be vigilant
108.2 Genome Biology 2007, Volume 8, Issue 7, Article 108 Petsko http://genomebiology.com/2007/8/7/108
Genome Biology 2007, 8:108about ethical concerns but not paralyzed by outlandish
scenarios. The belief of biologists that studying simple
organisms such as Escherichia coli, flies, and rats is relevant
to human physiology and behavior has been brilliantly
confirmed. But there are differences. One cannot extrapolate
carcinogenic potency from the mouse to the rat with
precision, and even less to the human. Some diseases involve
speech and mental states unique to man. Sequencing the
human genome puts us on the threshold of great new
benefits and some real but avoidable risks. There are
immoralities of commission that we must avoid. But there is
also the immorality of omission - the failure to apply a great
new technology to aid the poor, the infirm, and the
underprivileged. We must step boldly and confidently across
the threshold." 
Dan was the doyen of biochemistry but nevertheless always
behaved like, and loved, the maverick. "Later in life," he
wrote a few years ago, "when I became editor-in-chief of the
journal Science, my early experience allowed me to keep a
friendly eye out for the non-conformist. But does science
have any lessons for non-conformism in other spheres, such
as politics and religion? Non-conformity is looked on with
more hostility by religion, government and culture than by
science - because each of them is more vulnerable to change
than science is. The other segments of our society have yet to
find a better mechanism for encouraging non-conformity to
achieve progress, while still controlling non-conformity to
prevent chaos. Science has achieved the best balance, but it
must fight to preserve this and serve as a beacon to other
sectors of our society." He was 85 when he wrote that. 
I last saw him a month ago, at a dinner in New York.
"Petsko," he said when he saw me (he never called me
Greg, not once in 35 years), "what mischief are you up to
now?" He actually looked disappointed when I told him I
was being good. 
I loved him greatly. I can't imagine what my life would have
been like without his encouragement, enthusiasm, and
interest. I know it would have been poorer. After he started
to show his physical age a few years ago, I made it a point,
every time I saw him, of telling him how much his friendship
meant to me. Now I think I still didn't say it often enough. 
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